Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H24F3N3O4 |
| Molecular Weight | 439.4282 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(N2C[C@@H](F)[C@@H](CNC3CC3)C2)C(F)=CC4=C1N(CCF)C=C(C(O)=O)C4=O
InChI
InChIKey=ZFIOCUITTUUVPV-MEDUHNTESA-N
InChI=1S/C21H24F3N3O4/c1-31-20-17-13(19(28)14(21(29)30)9-26(17)5-4-22)6-15(23)18(20)27-8-11(16(24)10-27)7-25-12-2-3-12/h6,9,11-12,16,25H,2-5,7-8,10H2,1H3,(H,29,30)/t11-,16+/m0/s1
| Molecular Formula | C21H24F3N3O4 |
| Molecular Weight | 439.4282 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| In Vitro Mechanistic Study of the Distribution of Lascufloxacin into Epithelial Lining Fluid. | 2019-04 |
|
| In vitro activity of lascufloxacin, a novel fluoroquinolone antibacterial agent, against various clinical isolates of anaerobes and Streptococcus anginosus group. | 2018-12 |
|
| Intrapulmonary Pharmacokinetics of Lascufloxacin in Healthy Adult Volunteers. | 2018-04 |
|
| In Vitro Activities and Spectrum of the Novel Fluoroquinolone Lascufloxacin (KRP-AM1977). | 2017-06 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:34:50 GMT 2025
by
admin
on
Mon Mar 31 18:34:50 GMT 2025
|
| Record UNII |
55MOB566V7
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5370
Created by
admin on Mon Mar 31 18:34:50 GMT 2025 , Edited by admin on Mon Mar 31 18:34:50 GMT 2025
|
PRIMARY | |||
|
Lascufloxacin
Created by
admin on Mon Mar 31 18:34:50 GMT 2025 , Edited by admin on Mon Mar 31 18:34:50 GMT 2025
|
PRIMARY | |||
|
300000019094
Created by
admin on Mon Mar 31 18:34:50 GMT 2025 , Edited by admin on Mon Mar 31 18:34:50 GMT 2025
|
PRIMARY | |||
|
71528768
Created by
admin on Mon Mar 31 18:34:50 GMT 2025 , Edited by admin on Mon Mar 31 18:34:50 GMT 2025
|
PRIMARY | |||
|
10017
Created by
admin on Mon Mar 31 18:34:50 GMT 2025 , Edited by admin on Mon Mar 31 18:34:50 GMT 2025
|
PRIMARY | |||
|
DTXSID001336967
Created by
admin on Mon Mar 31 18:34:50 GMT 2025 , Edited by admin on Mon Mar 31 18:34:50 GMT 2025
|
PRIMARY | |||
|
848416-07-9
Created by
admin on Mon Mar 31 18:34:50 GMT 2025 , Edited by admin on Mon Mar 31 18:34:50 GMT 2025
|
PRIMARY | |||
|
C166817
Created by
admin on Mon Mar 31 18:34:50 GMT 2025 , Edited by admin on Mon Mar 31 18:34:50 GMT 2025
|
PRIMARY | |||
|
55MOB566V7
Created by
admin on Mon Mar 31 18:34:50 GMT 2025 , Edited by admin on Mon Mar 31 18:34:50 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|